CA2080566A1 - Compositions pharmaceutiques contenant des derives de triazole pour administration par voie rectale - Google Patents

Compositions pharmaceutiques contenant des derives de triazole pour administration par voie rectale

Info

Publication number
CA2080566A1
CA2080566A1 CA2080566A CA2080566A CA2080566A1 CA 2080566 A1 CA2080566 A1 CA 2080566A1 CA 2080566 A CA2080566 A CA 2080566A CA 2080566 A CA2080566 A CA 2080566A CA 2080566 A1 CA2080566 A1 CA 2080566A1
Authority
CA
Canada
Prior art keywords
pharmaceutical compositions
rectal administration
triazole derivatives
compositions containing
containing triazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2080566A
Other languages
English (en)
Other versions
CA2080566C (fr
Inventor
Walter Fries
Guenther Pfaff
Joerg Pfitzner
Gerhard Simon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heinrich Mack Nachf GmbH and Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2080566A1 publication Critical patent/CA2080566A1/fr
Application granted granted Critical
Publication of CA2080566C publication Critical patent/CA2080566C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002080566A 1991-10-15 1992-10-14 Compositions pharmaceutiques contenant des derives de triazole pour administration par voie rectale Expired - Fee Related CA2080566C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4134125A DE4134125C2 (de) 1991-10-15 1991-10-15 Triazol-Derivate enthaltende pharmazeutische Zusammensetzungen zur rektalen Applikation
DEP4134125.2 1991-10-15

Publications (2)

Publication Number Publication Date
CA2080566A1 true CA2080566A1 (fr) 1993-04-16
CA2080566C CA2080566C (fr) 1998-02-17

Family

ID=6442729

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002080566A Expired - Fee Related CA2080566C (fr) 1991-10-15 1992-10-14 Compositions pharmaceutiques contenant des derives de triazole pour administration par voie rectale

Country Status (18)

Country Link
EP (1) EP0537729B1 (fr)
JP (1) JPH05294830A (fr)
KR (1) KR930007446A (fr)
AT (1) ATE150970T1 (fr)
CA (1) CA2080566C (fr)
DE (2) DE4134125C2 (fr)
DK (1) DK0537729T3 (fr)
ES (1) ES2100998T3 (fr)
FI (1) FI107232B (fr)
GR (1) GR3023552T3 (fr)
HU (1) HU213202B (fr)
IL (1) IL103398A (fr)
MX (1) MX9205898A (fr)
MY (1) MY108576A (fr)
NO (1) NO923992L (fr)
NZ (1) NZ244734A (fr)
TW (1) TW258661B (fr)
ZA (1) ZA927907B (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2078719B (en) * 1980-06-02 1984-04-26 Ici Ltd Heterocyclic compounds
EP0069442B1 (fr) * 1981-06-06 1985-02-20 Pfizer Limited Agents antifongiques, procédé de leur préparation et compositions pharmaceutiques les contenant
GR79307B (fr) * 1982-06-09 1984-10-22 Pfizer
DE3307217A1 (de) * 1983-03-02 1984-09-06 Bayer Ag, 5090 Leverkusen Substituierte 1,3-diazolyl-2-propanole, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel

Also Published As

Publication number Publication date
FI924639L (fi) 1993-04-16
DE69218718D1 (de) 1997-05-07
KR930007446A (ko) 1993-05-20
TW258661B (fr) 1995-10-01
IL103398A (en) 1997-08-14
NO923992D0 (no) 1992-10-14
EP0537729B1 (fr) 1997-04-02
FI107232B (fi) 2001-06-29
EP0537729A1 (fr) 1993-04-21
JPH05294830A (ja) 1993-11-09
DE4134125C2 (de) 1995-02-02
DK0537729T3 (da) 1997-09-22
IL103398A0 (en) 1993-03-15
ES2100998T3 (es) 1997-07-01
DE69218718T2 (de) 1997-08-07
NZ244734A (en) 1994-12-22
DE4134125A1 (de) 1993-04-22
HU9203236D0 (en) 1992-12-28
HUT65417A (en) 1994-06-28
CA2080566C (fr) 1998-02-17
MX9205898A (es) 1993-05-01
ZA927907B (en) 1993-04-21
GR3023552T3 (en) 1997-08-29
MY108576A (en) 1996-10-31
ATE150970T1 (de) 1997-04-15
NO923992L (no) 1993-04-16
FI924639A0 (fi) 1992-10-14
HU213202B (en) 1997-03-28

Similar Documents

Publication Publication Date Title
CA2285891A1 (fr) Antifongiques a base de triazole
CA2073686A1 (fr) N-n'-dihaloimidazolidin-4-ones
WO2001009103A3 (fr) Agents antiproliferatifs imidazole
WO1993018031A1 (fr) Derive de pyrazole
CA2118937A1 (fr) Antifongiques a base de triazole
CA2088692A1 (fr) Compositions fongicides
IE790099L (en) Compositions containing azolyltriazine derivatives
IE840451L (en) Triazolylpropanols.
AU559703B2 (en) Triazole antifungal agents
IL77151A0 (en) Triazole derivatives,their use as fungicides and pharmaceutical compositions containing them
TW350757B (en) Benzisoxazole derivatives and pesticidal compositions containing them
CA2080566A1 (fr) Compositions pharmaceutiques contenant des derives de triazole pour administration par voie rectale
TW371300B (en) Process for converting 2,4-dichloropyridines into 2-aryloxy-4-chloropyridines
CA2104515A1 (fr) Composition accelerant la cicatrisation
CA2317691A1 (fr) Derives de triazole a activite antifongique
AU640767B2 (en) 15-deoxyprostaglandin derivative
CA2345717A1 (fr) Procede de fabrication de derives de trion-bis(oxime-ether) et derives de trion-mono- et de trion-bis(oxime-ether) ainsi obtenus
EP1632228A4 (fr) Composition medicinale contenant un compose triazole
GEP19970808B (en) Fungicide agent in the form of wettable powder
MX9709429A (es) Procedimiento para la conversion de 2,4-dicloropiridinas en 2-ariloxi-4-cloropiridinas.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed